Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Voting Common Stock, par value $0.0001 per share
-
Shares outstanding
-
52.4M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
9.68M
-
Shares change
-
+274K
-
Total reported value, excl. options
-
$30.4M
-
Value change
-
+$1.53M
-
Number of buys
-
12
-
Number of sells
-
-10
-
Price
-
$3.14
Significant Holders of TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) as of Q2 2022
30 filings reported holding TCRX - TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share as of Q2 2022.
TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.68M shares
of 52.4M outstanding shares and own 18.48% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2.78M shares), BlackRock Inc. (1.51M shares), Deer Management Co. LLC (1.25M shares), Alphabet Inc. (1.08M shares), TANG CAPITAL MANAGEMENT LLC (748K shares), DC Funds, LP (630K shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (550K shares), Newtyn Management, LLC (249K shares), VANGUARD GROUP INC (226K shares), and Tekla Capital Management LLC (200K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.